Why the study?
How does multimodality imaging differentiate tumour thrombus from bland thrombus in cancer patients?
How does multimodality imaging differentiate tumour thrombus from bland thrombus in cancer patients?
Multimodality imaging plays a crucial role in differentiating tumoural from bland thrombus in cancer patients, which impacts prognosis and management.
Answers are grounded in this paper and cite their sources.
May guide thrombus differentiation in cancer patients; leaves open prospective validation of imaging criteria.
Vascular thrombosis occurs commonly in cancer patients. Once the diagnosis of thrombosis is established, it is important to characterize the nature of thrombus, tumoural versus bland, as each have a different prognosis, clinical significance, and management. This review paper discusses the imaging spectrum of tumour thrombus and its clinical significance emphasizing the role of imaging in differentiating tumour from bland thrombus.
No takes yet. Share an insight, caveat, or question.
Rohatgi et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: